FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor

FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor kdunleavy Fri, 08/02/2024 - 08:14